Bifogade filer
Kurs
+5,59%
Prenumeration
Kalender
| Est. tid* | ||
| 2027-02-16 | 08:30 | Bokslutskommuniké 2026 |
| 2026-11-03 | 08:30 | Kvartalsrapport 2026-Q3 |
| 2026-09-01 | 08:30 | Kvartalsrapport 2026-Q2 |
| 2026-04-28 | 08:30 | Kvartalsrapport 2026-Q1 |
| 2026-02-16 | 08:30 | Bokslutskommuniké 2025 |
| 2025-11-03 | - | Kvartalsrapport 2025-Q3 |
| 2025-08-29 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-30 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2025-05-28 | - | Årsstämma |
| 2025-04-25 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-14 | - | Bokslutskommuniké 2024 |
| 2024-11-01 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-31 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2024-05-30 | - | Årsstämma |
| 2024-04-26 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-09 | - | Bokslutskommuniké 2023 |
| 2023-12-21 | - | Extra Bolagsstämma 2024 |
| 2023-11-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-12 | - | Kvartalsrapport 2023-Q1 |
| 2023-04-06 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2023-04-05 | - | Årsstämma |
| 2023-02-03 | - | Bokslutskommuniké 2022 |
| 2022-11-07 | - | Kvartalsrapport 2022-Q3 |
| 2022-10-05 | - | Extra Bolagsstämma 2022 |
| 2022-08-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-15 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2022-06-14 | - | Årsstämma |
| 2022-04-29 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-18 | - | Bokslutskommuniké 2021 |
| 2021-11-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-09-23 | - | Extra Bolagsstämma 2021 |
| 2021-08-30 | - | Kvartalsrapport 2021-Q2 |
| 2021-06-28 | - | Årsstämma |
| 2021-06-15 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-19 | - | Bokslutskommuniké 2020 |
| 2020-11-09 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-26 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2020-06-25 | - | Årsstämma |
| 2020-05-11 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-05-10 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2019-05-06 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-10 | - | Årsstämma |
| 2019-02-28 | - | Bokslutskommuniké 2018 |
| 2018-12-18 | - | Extra Bolagsstämma 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-29 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-24 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-12 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2018-04-11 | - | Årsstämma |
| 2018-03-22 | - | Bokslutskommuniké 2017 |
| 2017-08-29 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-09 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-26 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2017-04-25 | - | Årsstämma |
| 2017-02-24 | - | Bokslutskommuniké 2016 |
| 2016-11-16 | - | Kvartalsrapport 2016-Q3 |
| 2016-10-19 | - | Extra Bolagsstämma 2016 |
| 2016-08-31 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-20 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-25 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2016-02-24 | - | Årsstämma |
| 2016-02-04 | - | Bokslutskommuniké 2015 |
| 2015-11-13 | - | Kvartalsrapport 2015-Q3 |
| 2015-09-04 | - | Kvartalsrapport 2015-Q2 |
| 2015-07-22 | - | Extra Bolagsstämma 2015 |
| 2015-05-07 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2015-05-06 | - | Årsstämma |
| 2015-04-17 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-20 | - | Bokslutskommuniké 2014 |
| 2014-12-17 | - | Extra Bolagsstämma 2014 |
| 2014-11-28 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-14 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-29 | - | Kvartalsrapport 2014-Q2 |
| 2014-06-12 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2014-06-11 | - | Årsstämma |
| 2014-05-16 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-21 | - | Bokslutskommuniké 2013 |
| 2013-11-15 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-28 | - | Kvartalsrapport 2013-Q2 |
| 2013-06-17 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2013-06-14 | - | Årsstämma |
| 2013-05-17 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-22 | - | Bokslutskommuniké 2012 |
| 2012-11-30 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-31 | - | Kvartalsrapport 2012-Q2 |
| 2012-06-20 | - | X-dag ordinarie utdelning IZAFE B 0.00 SEK |
| 2012-06-19 | - | Årsstämma |
| 2012-04-20 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-21 | - | Bokslutskommuniké 2011 |
| 2011-11-04 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-12 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-06 | - | Kvartalsrapport 2011-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
iZafe Group AB (publ.) announces that the company has entered into a strategic partnership with Vakt og Alarm, one of Norway’s most established providers of safety and alarm services for the care and welfare sector. Through the partnership, Vakt og Alarm will be responsible for the distribution, installation, and support of the Dosell medication dispenser in Norway, while iZafe Group focuses on product development and deeper integrations with healthcare and welfare systems.
The partnership builds on Dosell’s existing integration with the UMO platform and the upcoming transition to the next-generation UMOcx. This enables fast, secure, and scalable implementation in Norwegian municipalities and meets the growing need for safe and digitalized medication management across the country.
As an early confirmation of the partnership’s strength, iZafe Group and Vakt og Alarm have already secured their first joint procurement in Norway. The procurement covers six municipalities with an initial volume of approximately 100 Dosell units. This represents a significant first deal and an important reference for the continued expansion in the Norwegian market.
The standstill period runs until 28 November, and the agreement is scheduled to enter into force on 1 February 2026.
This initial success clearly demonstrates that iZafe Group’s strategy – combining deep technical integration with strong local presence through partners – is already delivering tangible results in the early stages of the company’s expansion in Norway.
– “We are pleased to initiate this collaboration with iZafe Group and see Dosell as a valuable addition to our range of safety solutions. With Dosell, we can offer our customers a proven and user-friendly solution for secure medication management – fully aligned with our mission to contribute to a safer everyday life for both users and care staff,” says Lillian S Lien, CEO of Vakt og Alarm AS.
With this first joint deal, iZafe Group and Vakt og Alarm are laying the foundation for a long-term and expanding collaboration in Norway. The procurement clearly shows how Dosell can be rapidly implemented and scaled within Norwegian care services and marks the beginning of a broader market establishment.
About Vakt og Alarm
Vakt og Alarm AS was founded in 1990 and is a leading Norwegian provider of safety and alarm services for the care and welfare sector. The company has delivered solutions to more than 250 municipalities across Norway and is headquartered in Etne. With an experienced team and a strong focus on quality and availability, Vakt og Alarm contributes to increased safety for both users and care staff throughout the country.
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. The company’s Certified Adviser is DNB Carnegie Investment Bank AB. Further information is available at www.izafegroup.com